Opus Genetics Files Definitive Proxy Materials
Ticker: IRD · Form: DEFA14A · Filed: Apr 14, 2025 · CIK: 1228627
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, sec-filing
TL;DR
Opus Genetics dropped more proxy docs, shareholders need to check 'em before voting.
AI Summary
Opus Genetics, Inc. filed a Definitive Additional Materials proxy statement on April 14, 2025. This filing relates to the company's solicitation of proxies for its upcoming shareholder meeting. The document is an amendment to previous filings and provides additional information for shareholders regarding the matters to be voted upon.
Why It Matters
This filing provides shareholders with crucial information and updates necessary for them to make informed decisions when voting on important company matters at the upcoming shareholder meeting.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement amendment and does not contain new financial information or strategic changes that would inherently increase risk.
Key Players & Entities
- Opus Genetics, Inc. (company) — Registrant
- 0001999371-25-004182 (filing_id) — Accession Number
- 20250414 (date) — Filing Date
FAQ
What type of filing is this?
This is a DEFA14A filing, specifically Definitive Additional Materials for a proxy statement.
Who is the filing company?
The filing company is Opus Genetics, Inc.
When was this filing submitted?
The filing was submitted on April 14, 2025.
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for Definitive Additional Materials, meaning it supplements previously filed proxy materials and is sent to shareholders.
Does this filing require a fee?
According to the filing, no fee was required.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 14, 2025 regarding Opus Genetics, Inc. (IRD).